Gossamer Bio Inc. issued 2,500,000 shares of its common stock to Prana Bio, Inc. on September 24, 2025, as consideration for an option to acquire Respira Therapeutics, Inc. The company also agreed to issue up to an additional 1,500,000 shares upon exercise of the merger option and up to approximately 6,688,964 more shares upon achievement of specified milestones. The total price for these shares was not disclosed in the document.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gossamer Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001728117-25-000076), on September 25, 2025, and is solely responsible for the information contained therein.